Concepedia

Martin Højgaard

MH

9

Publications

465

Citations

9

H-Index

2006

Active since

Affiliations

Rigshospitalet(Current)

University of Copenhagen

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

Brown University

Martin Højgaard is an author at Rigshospitalet specializing in medicine, cancer therapeutics, and tumor biology.

ORCID

Top concepts

Publications per year

2006–2023

9

Publications

9

Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors

François Doz, Cornelis M. van Tilburg, Birgit Geoerger et al. · Neuro-Oncology · 2021 · 154 citations · Full text

Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results

Timothy A. Yap, Elisa Fontana, Elizabeth K. Lee et al. · Nature Medicine · 2023 · 94 citations · Full text

Elimination of Ascorbic Acid After High‐Dose Infusion in Prostate Cancer Patients: A Pharmacokinetic Evaluation

Torben Kjær Nielsen, Martin Højgaard, Jón Trærup Andersen et al. · Basic & Clinical Pharmacology & Toxicology · 2014 · 71 citations

Weekly ascorbic acid infusion in castration-resistant prostate cancer patients: a single-arm phase II trial

Torben Kjær Nielsen, Martin Højgaard, Jón Trærup Andersen et al. · Translational Andrology and Urology · 2017 · 51 citations · Full text

The plasma atrial natriuretic peptide response to arm and leg exercise in humans: effect of posture

Thomas W. Vogelsang, Chie Yoshiga, Martin Højgaard et al. · Experimental Physiology · 2006 · 24 citations · Full text

, , +15

Rows per page

1–5 of 9